Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Glioma progression through synaptic activity.

Lim-Fat MJ, Wen PY.

Nat Rev Neurol. 2020 Jan;16(1):6-7. doi: 10.1038/s41582-019-0290-1. No abstract available.

PMID:
31745299
2.

Electrical and synaptic integration of glioma into neural circuits.

Venkatesh HS, Morishita W, Geraghty AC, Silverbush D, Gillespie SM, Arzt M, Tam LT, Espenel C, Ponnuswami A, Ni L, Woo PJ, Taylor KR, Agarwal A, Regev A, Brang D, Vogel H, Hervey-Jumper S, Bergles DE, Suvà ML, Malenka RC, Monje M.

Nature. 2019 Sep;573(7775):539-545. doi: 10.1038/s41586-019-1563-y. Epub 2019 Sep 18.

PMID:
31534222
3.

Glutamatergic synaptic input to glioma cells drives brain tumour progression.

Venkataramani V, Tanev DI, Strahle C, Studier-Fischer A, Fankhauser L, Kessler T, Körber C, Kardorff M, Ratliff M, Xie R, Horstmann H, Messer M, Paik SP, Knabbe J, Sahm F, Kurz FT, Acikgöz AA, Herrmannsdörfer F, Agarwal A, Bergles DE, Chalmers A, Miletic H, Turcan S, Mawrin C, Hänggi D, Liu HK, Wick W, Winkler F, Kuner T.

Nature. 2019 Sep;573(7775):532-538. doi: 10.1038/s41586-019-1564-x. Epub 2019 Sep 18.

PMID:
31534219
4.

Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma.

Derks J, Wesseling P, Carbo EWS, Hillebrand A, van Dellen E, de Witt Hamer PC, Klein M, Schenk GJ, Geurts JJG, Reijneveld JC, Douw L.

J Neurooncol. 2018 Nov;140(2):403-412. doi: 10.1007/s11060-018-2967-5. Epub 2018 Aug 9.

5.

Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Hu B, Guo P, Bar-Joseph I, Imanishi Y, Jarzynka MJ, Bogler O, Mikkelsen T, Hirose T, Nishikawa R, Cheng SY.

Oncogene. 2007 Aug 16;26(38):5577-86. Epub 2007 Mar 19.

6.

Neuropilin-1 (NRP-1)/GIPC1 pathway mediates glioma progression.

Zhang G, Chen L, Sun K, Khan AA, Yan J, Liu H, Lu A, Gu N.

Tumour Biol. 2016 Oct;37(10):13777-13788. Epub 2016 Aug 1.

PMID:
27481513
7.

Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma.

Venkatesh HS, Tam LT, Woo PJ, Lennon J, Nagaraja S, Gillespie SM, Ni J, Duveau DY, Morris PJ, Zhao JJ, Thomas CJ, Monje M.

Nature. 2017 Sep 28;549(7673):533-537. doi: 10.1038/nature24014. Epub 2017 Sep 20.

8.

Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.

Hau P, Ruemmele P, Kunz-Schughart LA, Doerfelt A, Hirschmann B, Lohmeier A, Koch H, Mueller A, Bogdahn U, Bosserhoff AK.

Oncol Rep. 2004 Dec;12(6):1355-64.

PMID:
15547763
9.

Golgi phosphoprotein 3 promotes glioma progression via inhibiting Rab5-mediated endocytosis and degradation of epidermal growth factor receptor.

Zhou X, Xie S, Wu S, Qi Y, Wang Z, Zhang H, Lu D, Wang X, Dong Y, Liu G, Yang D, Shi Q, Bian W, Yu R.

Neuro Oncol. 2017 Nov 29;19(12):1628-1639. doi: 10.1093/neuonc/nox104.

10.

Impaired hippocampal synaptic plasticity in C6 glioma-bearing rats.

Wang YY, Liu SC, Yang Z, Zhang T.

J Neurooncol. 2011 Jul;103(3):469-77. doi: 10.1007/s11060-010-0447-7. Epub 2010 Nov 10.

PMID:
21063897
11.

Identification of expression quantitative trait loci of MTOR associated with the progression of glioma.

Huang L, Dai L, Xu W, Zhang S, Yan D, Shi X.

Oncol Lett. 2018 Jan;15(1):665-671. doi: 10.3892/ol.2017.7319. Epub 2017 Nov 1.

12.

Dissecting dysfunctional crosstalk pathways regulated by miRNAs during glioma progression.

Zhang Y, Xu Y, Li F, Li X, Feng L, Shi X, Wang L, Li X.

Oncotarget. 2016 May 3;7(18):25769-82. doi: 10.18632/oncotarget.8265.

13.

Inhibition of glioma progression by a newly discovered CD38 inhibitor.

Blacher E, Ben Baruch B, Levy A, Geva N, Green KD, Garneau-Tsodikova S, Fridman M, Stein R.

Int J Cancer. 2015 Mar 15;136(6):1422-33. doi: 10.1002/ijc.29095. Epub 2014 Aug 7.

14.

Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting.

Appolloni I, Alessandrini F, Ceresa D, Marubbi D, Gambini E, Reverberi D, Loiacono F, Malatesta P.

Cancer Lett. 2019 Feb 1;442:213-221. doi: 10.1016/j.canlet.2018.10.006. Epub 2018 Oct 9.

PMID:
30312732
15.

Diagnostic Performance of Increased Signal Intensity Within the Resection Cavity on Fluid-Attenuated Inversion Recovery Sequences for Detection of Progression in Patients with Glioma.

Zhang J, Song Y, He M, Ren Q, Zeng Y, Liu Z, Liu H, Xu J.

World Neurosurg. 2018 Feb;110:434-441. doi: 10.1016/j.wneu.2017.11.181. Epub 2017 Dec 9. Review.

PMID:
29229341
16.

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T, Hoang-Xuan K, Brandes AA, Kantor G, Taphoorn MJB, Hassel MB, Hartmann C, Ryan G, Capper D, Kros JM, Kurscheid S, Wick W, Enting R, Reni M, Thiessen B, Dhermain F, Bromberg JE, Feuvret L, Reijneveld JC, Chinot O, Gijtenbeek JMM, Rossiter JP, Dif N, Balana C, Bravo-Marques J, Clement PM, Marosi C, Tzuk-Shina T, Nordal RA, Rees J, Lacombe D, Mason WP, Stupp R.

Lancet Oncol. 2016 Nov;17(11):1521-1532. doi: 10.1016/S1470-2045(16)30313-8. Epub 2016 Sep 27.

17.

Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?

Unterrainer M, Schweisthal F, Suchorska B, Wenter V, Schmid-Tannwald C, Fendler WP, Schüller U, Bartenstein P, Tonn JC, Albert NL.

J Nucl Med. 2016 Aug;57(8):1177-82. doi: 10.2967/jnumed.115.171033. Epub 2016 Mar 31.

18.

Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression.

Li Y, Xu J, Chen H, Bai J, Li S, Zhao Z, Shao T, Jiang T, Ren H, Kang C, Li X.

Nucleic Acids Res. 2013 Dec;41(22):e203. doi: 10.1093/nar/gkt1054. Epub 2013 Nov 4.

19.

Characterization of Transcriptome Transition Associates Long Noncoding RNAs with Glioma Progression.

Lin X, Jiang T, Bai J, Li J, Wang T, Xiao J, Tian Y, Jin X, Shao T, Xu J, Chen L, Wang L, Li Y.

Mol Ther Nucleic Acids. 2018 Dec 7;13:620-632. doi: 10.1016/j.omtn.2018.10.009. Epub 2018 Oct 24.

20.

Roles of microRNAs during glioma tumorigenesis and progression.

Wang S, Yin Y, Liu S.

Histol Histopathol. 2019 Mar;34(3):213-222. doi: 10.14670/HH-18-040. Epub 2018 Sep 14. Review.

PMID:
30215456

Supplemental Content

Support Center